NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vectus Biosystems Limited (AU: VBS)

 
VBS Technical Analysis
3
As on 23rd Oct 2025 VBS STOCK Price closed @ 0.14 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.09 & Buy for SHORT-TERM with Stoploss of 0.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VBSSTOCK Price

Open 0.18 Change Price %
High 0.19 1 Day 0.07 100.00
Low 0.12 1 Week 0.07 100.00
Close 0.14 1 Month 0.07 100.00
Volume 101557 1 Year -0.11 -44.00
52 Week High 0.28 | 52 Week Low 0.04
 
AU Australia Most Active Stocks
RML 0.08 %
THR 0.02 100.00%
ARU 0.46 9.52%
AXI 0.02 0.00%
ADN 0.02 %
LMG 0.04 33.33%
SGQ 0.12 0.00%
ROG 0.01 %
VR1 0.05 %
EUR 0.26 4.00%
 
AU Australia Top Gainers Stocks
AS2 0.02 100.00%
AS2 0.02 100.00%
THR 0.02 100.00%
THR 0.02 100.00%
THR 0.02 100.00%
NWM 0.02 100.00%
NWM 0.02 100.00%
NWM 0.02 100.00%
APV 0.02 100.00%
VBS 0.14 100.00%
 
AU Australia Top Losers Stocks
RIM 0.01 -50.00%
ASQ 0.02 -33.33%
AAJ 0.02 -33.33%
AAJ 0.02 -33.33%
AAJ 0.02 -33.33%
RCP 0.02 -33.33%
RCP 0.02 -33.33%
CAE 0.05 -28.57%
CAE 0.05 -28.57%
CAE 0.05 -28.57%
 
 
VBS
Daily Charts
VBS
Intraday Charts
Whats New @
Bazaartrend
VBS
Free Analysis
 
VBS Important Levels Intraday
RESISTANCE0.27
RESISTANCE0.23
RESISTANCE0.20
RESISTANCE0.18
SUPPORT0.10
SUPPORT0.08
SUPPORT0.05
SUPPORT0.01
 
VBS Forecast October 2025
4th UP Forecast0.24
3rd UP Forecast0.21
2nd UP Forecast0.19
1st UP Forecast0.17
1st DOWN Forecast0.11
2nd DOWN Forecast0.09
3rd DOWN Forecast0.07
4th DOWN Forecast0.04
 
VBS Weekly Forecast
4th UP Forecast0.14
3rd UP Forecast0.14
2nd UP Forecast0.14
1st UP Forecast0.14
1st DOWN Forecast0.14
2nd DOWN Forecast0.14
3rd DOWN Forecast0.14
4th DOWN Forecast0.14
 
VBS Forecast2025
4th UP Forecast0.54
3rd UP Forecast0.41
2nd UP Forecast0.33
1st UP Forecast0.25
1st DOWN Forecast0.03
2nd DOWN Forecast-0.05
3rd DOWN Forecast-0.13
4th DOWN Forecast-0.26
 
 
VBS Other Details
Segment EQ
Market Capital 56410784.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VBS Address
VBS
 
VBS Latest News
 
Your Comments and Response on Vectus Biosystems Limited
 
VBS Business Profile
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that improves speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was founded in 2005 and is based in Rosebery, Australia. Address: 3-11 Primrose Avenue, Rosebery, NSW, Australia, 2018
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service